{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:04:54Z","timestamp":1784559894648,"version":"3.55.0"},"reference-count":31,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"DOI":"10.61622\/rbgo\/2026rbgo52","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:46:14Z","timestamp":1784558774000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of different EMA\/CO treatment regimens in women with gestational trophoblastic neoplasia: brazilian multicenter retrospective cohort study"],"prefix":"10.61622","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7786-6713","authenticated-orcid":false,"given":"La\u00eds Cristhine Santos","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-513X","authenticated-orcid":false,"given":"Michelle Samora de","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-6182","authenticated-orcid":false,"given":"Antonio","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-4713","authenticated-orcid":false,"given":"Jos\u00e9 Mauro","family":"Madi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6145-2532","authenticated-orcid":false,"suffix":"J\u00fanior","given":"Edward","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1655-3609","authenticated-orcid":false,"given":"Alberto Borges","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1547-6689","authenticated-orcid":false,"given":"Marcio Bezerra","family":"Barcellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-4991","authenticated-orcid":false,"given":"Lucas Ribeiro Borges de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-0369","authenticated-orcid":false,"suffix":"Filho","given":"Roney Cesar","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-7386","authenticated-orcid":false,"given":"Sue Yazaki","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"issue":"Suppl 1","key":"key20260720144605_B1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ijgo.70275","article-title":"Diagnosis and management of gestational trophoblastic disease: 2025 update","volume":"171","author":"Ngan","year":"2025","unstructured":"1 Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2025 update. Int J Gynaecol Obstet. 2025;171(Suppl 1):78-86. doi: 10.1002\/ijgo.70275","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"key20260720144605_B2","first-page":"e1","article-title":"Management of Gestational Trophoblastic Disease: Green-top Guideline No. 38 - June 2020","volume":"128","year":"2021","unstructured":"2 Management of Gestational Trophoblastic Disease: Green-top Guideline No. 38 - June 2020. BJOG. 2021;128(3):e1-e27. doi: 10.1111\/1471-0528.16266.","journal-title":"BJOG"},{"issue":"3","key":"key20260720144605_B3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000534321","article-title":"From National to International Collaboration in Gestational Trophoblastic Disease: hurdles and Possibilities","volume":"89","author":"Golfier","year":"2024","unstructured":"3 Golfier F, Seckl MJ. From National to International Collaboration in Gestational Trophoblastic Disease: hurdles and Possibilities. Gynecol Obstet Invest. 2024;89(3):254\u20138. doi: 10.1159\/000534321","journal-title":"Gynecol Obstet Invest"},{"issue":"9742","key":"key20260720144605_B4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","unstructured":"4 Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010; 376(9742):717\u201329. doi: 10.1016\/S0140-6736(10)60280-2","journal-title":"Lancet"},{"issue":"2","key":"key20260720144605_B5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ogc.2012.03.002","article-title":"Gestational trophoblastic neoplasia","volume":"39","author":"Osborne","year":"2012","unstructured":"5 Osborne R, Dodge J. Gestational trophoblastic neoplasia. Obstet Gynecol Clin North Am. 2012; 39(2):195-212. doi: 10.1016\/j.ogc.2012.03.002","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"key20260720144605_B6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4132\/KoreanJPathol.2013.47.1.67","article-title":"Epithelioide trophoblastic tumor: clinicopathologic and immunohistochemical analysis of tree cases","volume":"47","author":"Sung","year":"2013","unstructured":"6 Sung WJ, Shin HC, Kim MK, Kim MJ. Epithelioide trophoblastic tumor: clinicopathologic and immunohistochemical analysis of tree cases. Korean J Pathol. 2013;47(1):67\u201373. doi: 10.4132\/KoreanJPathol.2013.47.1.67","journal-title":"Korean J Pathol"},{"issue":"1","key":"key20260720144605_B7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1479-828X.2009.01114.x","article-title":"Persistence and malignant sequelae of gestational trophoblastic disease: Clinical presentation, diagnosis, treatment and outcome","volume":"50","author":"Khoo","year":"2010","unstructured":"7 Khoo SK, Sidhu M, Baartz D, Yip WL, Tripcony L. Persistence and malignant sequelae of gestational trophoblastic disease: Clinical presentation, diagnosis, treatment and outcome. Aust N Z J Obstet Gynaecol. 2010; 50(1): 81-6. doi: 10.1111\/j.1479-828X.2009.01114.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5-6","key":"key20260720144605_B8","first-page":"241","article-title":"Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 brazilian referral centers results after 12 years since International FIGO 2000 Consensus","volume":"59","author":"Braga","year":"2014","unstructured":"8 Braga A, Uberti EM, Fajardo MC, Viggiano M, Sun SY, Grillo BM, et al. Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 brazilian referral centers results after 12 years since International FIGO 2000 Consensus. J Reprod Med. 2014; 59(5-6): 241\u20137.","journal-title":"J Reprod Med"},{"issue":"16","key":"key20260720144605_B9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMcp0900696","article-title":"Clinical practice. Molar pregnancy","volume":"360","author":"Berkowitz","year":"2009","unstructured":"9 Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Eng J Med. 2009; 360(16): 39-45. doi: 10.1056\/NEJMcp0900696","journal-title":"N Eng J Med"},{"issue":"3","key":"key20260720144605_B10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee","volume":"77","author":"FIGO Oncology Committee Report","year":"2002","unstructured":"10 FIGO Oncology Committee Report. FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. Int J Gynaecol Obstet. 2002; 77(3):285-7. doi: 10.1016\/s0020-7292(02)00063-2","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"key20260720144605_B11","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e87","article-title":"Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia","volume":"30","author":"Paulino","year":"2019","unstructured":"11 Paulino E, de Melo AC. Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia. J Gynecol Oncol. 2019; 30(4):e87. doi: 10.3802\/jgo.2019.30.e87","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"key20260720144605_B12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ygyno.2016.10.001","article-title":"Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia","volume":"143","author":"Winter","year":"2016","unstructured":"12 Winter MC, Tidy JA, Hills A, Ireson J, Gillett S, Singh S, et al. Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2016; 143(3):565\u201370. doi: 10.1016\/j.ygyno.2016.10.001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"key20260720144605_B13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ijgc-00009577-200101000-00011","article-title":"The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment","volume":"11","author":"Kohorn","year":"2001","unstructured":"13 Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001; 11(1):73-7. doi: 10.1046\/j.1525-1438.2001.011001073.x","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"key20260720144605_B14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygyno.2006.02.038","article-title":"What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence","volume":"102","author":"Foulmann","year":"2006","unstructured":"14 Foulmann K, Guastalla JP, Caminet N, Trillet-Lenoir V, Raudrant D, Golfier F, et al. What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence. Gynecol Oncol. 2006; 102(1):103-10. doi: 10.1016\/j.ygyno.2006.02.038","journal-title":"Gynecol Oncol"},{"issue":"3","key":"key20260720144605_B15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ygyno.2020.09.046","article-title":"Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy","volume":"159","author":"Jareemit","year":"2020","unstructured":"15 Jareemit N, Horowitz NS, Goldstein DP, Berkowitz RS, Elias KM. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy. Gynecol Oncol. 2020; 159(3):751-757. doi: 10.1016\/j.ygyno.2020.09.046","journal-title":"Gynecol Oncol"},{"issue":"1","key":"key20260720144605_B16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2019.07.024","article-title":"When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients","volume":"155","author":"Balachandran","year":"2019","unstructured":"16 Balachandran K, Salawu A, Ghorani E, Kaur B, Sebire NJ, Short D, et al. When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients. Gynecol Oncol. 2019; 155(1):8-12. doi: 10.1016\/j.ygyno.2019.07.024","journal-title":"Gynecol Oncol"},{"key":"key20260720144605_B17","author":"U.S. Department of Health and Human Services Common Terminology","year":"2017","unstructured":"17 U.S. Department of Health and Human Services Common Terminology. Common Terminology Criteria for Adverse Events. Version 5.0, november 27, 2017 [cited 2026 Jun 1]. Available from: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf","journal-title":"Common Terminology Criteria for Adverse Events"},{"issue":"2","key":"key20260720144605_B18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2019.03.005","article-title":"Can carboplatin or etoposide replace actinomycin-D for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?","volume":"153","author":"Mora","year":"2019","unstructured":"18 Mora PA, Sun SY, Velarde GC, Rezende Filho J, Uberti EH, Dos Santos Esteves AP, et al. Can carboplatin or etoposide replace actinomycin-D for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia? Gynecol Oncol. 2019; 153(2):277-85. doi: 10.1016\/j.ygyno.2019.03.005","journal-title":"Gynecol Oncol"},{"issue":"7","key":"key20260720144605_B19","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","unstructured":"19 Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, et al. EMA\/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol. 1997; 15(7):2636-43. doi: 10.1200\/JCO.1997.15.7.2636","journal-title":"J Clin Oncol"},{"issue":"1","key":"key20260720144605_B20","article-title":"Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia","volume":"2016","author":"Alazzam","year":"2016","unstructured":"20 Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2016; 2016(1):CD008891. doi: 10.1002\/14651858.CD008891.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"5-7","key":"key20260720144605_B21","first-page":"262","article-title":"Survival of women with gestational trophoblastic neoplasia and liver metastases: Is it improving?","volume":"57","author":"Ahamed","year":"2012","unstructured":"21 Ahamed E, Short D, North B, Savage PM, Seckl MJ. Survival of women with gestational trophoblastic neoplasia and liver metastases: Is it improving? J Reprod Med. 2012; 57(5-7):262\u20139.","journal-title":"J Reprod Med"},{"issue":"7","key":"key20260720144605_B22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(23)00289-9","article-title":"Cancer care critically affected by USA drug shortages","volume":"24","author":"Gourd","year":"2023","unstructured":"22 Gourd E. Cancer care critically affected by USA drug shortages. Lancet Oncol. 2023; 24(7):727. doi: 10.1016\/S1470-2045(23)00289-9","journal-title":"Lancet Oncol"},{"key":"key20260720144605_B23","first-page":"192","article-title":"Treatment of trophoblastic tumours","volume":"62","author":"Bagshawe","year":"1977","unstructured":"23 Bagshawe KD. Treatment of trophoblastic tumours. Recent Results Cancer Res. 1977; 62:192\u20139. doi: 10.1007\/978-3-642-81174-6_29","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"key20260720144605_B24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005196.pub3","article-title":"Combination chemotherapy for high-risk gestational trophoblastic tumour","author":"Deng","year":"2009","unstructured":"24 Deng L, Yan X, Zhang J, Wu T. Combination chemotherapy for high-risk gestational trophoblastic tumour. Cochrane Database Syst Rev. 2009; (2):CD005196. doi: 10.1002\/14651858.CD005196.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"key20260720144605_B25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1471-0528.1991.tb10369.x","article-title":"Results with the EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumours 1979 to 1989","volume":"98","author":"Newlands","year":"1991","unstructured":"25 Newlands ES, Bagshawe KD, Begent RH, Rustin GJ, Holden L. Results with the EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumours 1979 to 1989. BJOG. 1991; 98(6):550-557. doi: 10.1111\/j.1471-0528.1991.tb10369.x","journal-title":"BJOG"},{"key":"key20260720144605_B26","first-page":"S85","article-title":"Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD","volume":"60 Suppl 1","author":"Kim","year":"1998","unstructured":"26 Kim SJ, Bae SN, Kim JH, Kim CT, Han KT, Lee JM, et al. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD. Int J Gynaecol Obstet. 1998; 60 Suppl 1:S85-96.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"key20260720144605_B27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4103\/ijmr.IJMR_2585_19","article-title":"Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia","volume":"152","author":"Singhal","year":"2020","unstructured":"27 Singhal S, Kumar L, Kumar S, Khurana S, Bhatla N. Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia. Indian J Med Res. 2020; 152(6):595-606. doi: 10.4103\/ijmr.IJMR_2585_19","journal-title":"Indian J Med Res"},{"issue":"3","key":"key20260720144605_B28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1631\/jzus.B2100895","article-title":"Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis","volume":"23","author":"Weng","year":"2022","unstructured":"28 Weng Y, Liu Y, Benjoed C, Wu X, Tang S, Li X, et al. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis. J Zhejiang Univ Sci B. 2022; 23(3):218-229. doi: 10.1631\/jzus.B2100895","journal-title":"J Zhejiang Univ Sci B"},{"issue":"8","key":"key20260720144605_B29","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(21)00262-X","article-title":"Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study","volume":"22","author":"Braga","year":"2021","unstructured":"29 Braga A, Paiva G, Ghorani E, Freitas F, Velarde LG, Kaur B, et al. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study. Lancet Oncol. 2021; 22(8):1188-1198. doi: 10.1016\/S1470-2045(21)00262-X.","journal-title":"Lancet Oncol"},{"issue":"5","key":"key20260720144605_B30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.2014.57.5332","article-title":"Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause","volume":"33","author":"Savage","year":"2015","unstructured":"30 Savage P, Cooke R, O\u2019Nions J, Krell J, Kwan A, Camarata M, et al. Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause. J Clin Oncol. 2015; 33(5):472-8. doi: 10.1200\/JCO.2014.57.5332.","journal-title":"J Clin Oncol"},{"issue":"4","key":"key20260720144605_B31","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e36","article-title":"The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy","volume":"31","author":"Wu","year":"2020","unstructured":"31 Wu X, Qin J, Shen T, Fei W, Chen L, Xie X, et al. The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy. J Gynecol Oncol. 2020; 31(4):e36. doi: 10.3802\/jgo.2020.31.e36","journal-title":"J Gynecol Oncol"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:46:19Z","timestamp":1784558779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/impact-of-different-ema-co-treatment-regimens-in-women-with-gestational-trophoblastic-neoplasia-brazilian-multicenter-retrospective-cohort-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"alternative-id":["10.61622\/rbgo\/2026rbgo52"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2026rbgo52","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e-rbgo52"}}